Scarica l'app Stockscreener
3.1701
6.54%
-0.1899
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.36
Aprire:
$3.36
Volume 24 ore:
2.76M
Relative Volume:
0.52
Capitalizzazione di mercato:
$57.04M
Reddito:
-
Utile/perdita netta:
$-43.27M
Rapporto P/E:
-2.0585
EPS:
-1.54
Flusso di cassa netto:
$-41.11M
1 W Prestazione:
-1.25%
1M Prestazione:
+19.40%
6M Prestazione:
-35.08%
1 anno Prestazione:
-92.76%
Intervallo 1D:
$3.00
$3.4278
Intervallo di 1 settimana:
$2.97
$3.85
Portata 52W:
$1.0404
$58.20
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| BIVI | 3.18 | 57.04M | 0 | -43.27M | -41.11M | -1.54 |
| VRTX | 449.82 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.84 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 594.98 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.78 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.90 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
Biovie Inc. to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long Covid At Theemystifying Long Covid International Conference - Marketscreener.com
BioVie to Present Design of Planned Phase 2 Study of - GlobeNewswire
BioVie's Long COVID Drug Trial Gets Pentagon Backing; Phase 2 Study to Include 200 Patients | BIVI Stock News - StockTitan
BioVie shareholders approve board nominees and equity plan expansion By Investing.com - Investing.com Canada
BioVie shareholders approve board nominees and equity plan expansion - Investing.com India
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded - GlobeNewswire
BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded - The Manila Times
BioVie Raises Capital Through Direct Stock Offering - MSN
BioVie Inc. Announces Closing of Registered Direct Offering - GlobeNewswire
BioVie Raises $3.24 Million in Direct Offering - TipRanks
BioVie sets price for $3.2 million stock offering By Investing.com - Investing.com Australia
BioVie sets price for $3.2 million stock offering - Investing.com India
BioVie prices stock offering at $2.83 per share By Investing.com - Investing.com Canada
BIVIBioVie, Inc. Latest Stock News & Market Updates - StockTitan
BioVie prices stock offering at $2.83 per share - Investing.com
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
Short Interest in BioVie Inc. (NASDAQ:BIVI) Decreases By 51.0% - MarketBeat
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Carson City, Nevada, October 23, 2024 — BioVie Inc. (NASDAQ: BIVI), a clinical-stage company focused on developing innovative drug therapies for ch - Defense World
BioVie Raises $6 Million in Strategic Funding - TipRanks
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - StockTitan
BioVie Announces $6 Million Stock Offering and Placement - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
BioVie announces $6 million stock offering and warrants By Investing.com - Investing.com Australia
BioVie announces $6 million stock offering and warrants - Investing.com India
BioVie 2.667M share registered direct offering priced at $2.25 - TipRanks
BioVie Inc. Announces Pricing of Registered Direct Offering - GlobeNewswire
BioVie stock dips after pricing offering to raise $6.66M - MSN
BioVie Announces Stock Offering and Private Placement - Yahoo Finance
Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - The Manila Times
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BioVie announces $6.7 million direct stock offering - Investing.com India
BioVie Secures $6.66 Million Through Direct Offering - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
3 Penny Stocks to Watch Now, 10/22/24 - TipRanks
BioVie stock dips after pricing offering to raise $6.66M (NASDAQ:BIVI) - Seeking Alpha
BioVie announces $6.7 million direct stock offering By Investing.com - Investing.com Australia
BioVie 4.443M share registered direct offering priced at $1.50 - TipRanks
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):